NDC 68180-801 – Lapatinib

Lapatinib Ditosylate 250 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC68180-801

Product details

Brand name
Lapatinib
Generic name
Lapatinib
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA203007
Marketed since
September 29, 2020
Listing expires
December 31, 2026
Pharmacologic class
Kinase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Lapatinib →

Package NDC codes (1)

Package NDCDescriptionSince
68180-801-36150 TABLET in 1 BOTTLE (68180-801-36)Sep 29, 2020

Other Lapatinib products